TLR8 (Toll Like Receptor 8)

News alerts, weekly reports and conference planners

Entrez ID:

TLR8 overexpression	Melanoma	TLR8 overexpression	Melanoma	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3
TLR8 expression	Lung Adenocarcinoma	TLR8 expression	Lung Adenocarcinoma	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
TLR8 overexpression	Squamous Cell Carcinoma of Head and Neck	TLR8 overexpression	Squamous Cell Carcinoma of Head and Neck	cetuximab + VTX 2337 Sensitive: D – Preclinical cetuximab + VTX 2337 Sensitive : D	cetuximab + VTX 2337 Sensitive: D – Preclinical cetuximab + VTX 2337 Sensitive : D

Associations(3)